Yu Wu

24PUBLICATIONS
41CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 12, 2026
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.

|Jul 09, 2026
Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia.

|Dec 21, 2025
CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study.

Jinjun Yang, Lian Wang, Min Zhu

|Nov 22, 2025
ASAH1-mediated sphingolipid metabolic reprogramming in venetoclax resistance of AML: beyond the monocytic phenotypes.

Lei Zhao, Xinrong Xiang, Ailing Zhong

|Oct 10, 2025
Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study.

Hongbin Yu, Tian Chen, Xin Zhang

|Aug 08, 2025
Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway.

Qing Li, Fangfang Wang, Xinrong Xiang

Pageof 4

Frequent Collaborators

3 joint publications

Yu Liu

3 joint publications

Hongbing Ma

2 joint publications

Xin Zhang

2 joint publications

Min Lu